| Intervention group (I) N = 43 | Control group (C) N = 42 |
---|---|---|
Demographic characteristics | Median (range) | Â |
Age | 61.0 (30 – 81) | 60.5 (35–79) |
Gender | n (%) | Â |
Male | 36 (83.7) | 35 (83.3) |
Female | 7 (16.3) | 7 (16.7) |
ECOG PS ≤1 | 34 (79.1) | 38 (90.5) |
Social status | Â | Â |
Married/living together | 31 (72.1) | 34 (81.0) |
Profession | Â | Â |
Labourer | 18 (41.9) | 17 (40.5) |
Employee | 20 (46.5) | 19 (45.2) |
Self-employed | 5 (11.6) | 5 (11.9) |
 | Median (Q1, Q3) |  |
Alcohol consumption (U/day) | 4.0 (1.0, 8.0) | 3.0 (1.0, 6.3) |
Tobacco consumption (PY) | 25.5 (8.6, 40.3) | 35.0 (17.8, 50.0) |
Clinical characteristics | n (%) | Â |
Tumour location | Â | Â |
Oral cavity | 11 (25.6) | 7 (16.7) |
Oropharynx | 17 (39.5) | 17 (40.5) |
Hypopharynx | 7 (16.3) | 4 (9.5) |
Nasopharynx | 2 (4.7) | 2 (4.8) |
Supraglottis | 2 (4.7) | 7 (16.7) |
Glottis | 2 (4.7) | 2 (4.8) |
Occult primary | 2 (4.7) | 3 (7.1) |
Tumour stage | Â | Â |
Early stage (I-II) | 6 (14.0) | 8 (19.0) |
Late stage (III-IVb) | 37 (86.0) | 34 (81.0) |
Therapy initiation | Â | Â |
Neoadjuvant chemotherapy + radiochemotherapy | 2 (4.7) | 4 (9.5) |
Primary radiotherapy | Â | Â |
 Alone | 7 (16.3) | 8 (19.0) |
 With chemotherapy | 22 (51.2) | 18 (42.9) |
 With biotherapy | 0 (0.0) | 2 (4.8) |
Adjuvant radiotherapy | Â | Â |
 Alone | 5 (11.6) | 3 (7.1) |
 With chemotherapy | 7 (16.3) | 7 (16.7) |
 With biotherapy | 0 (0.0) | 0 (0.0) |
Nutritional characteristics | Median (Q1, Q3) | Â |
6-months weight loss (%) | 2.5 (6.8, −1.5) | 2.2 (5.4, 2.4) |
BMI (kg/m2) | 22.80 (20.50, 28.70) | 24.25 (21.8, 27.2) |
PG-SGA score | 10.0 (5.0, 15.0) | 8.5 (6.8, 13.0) |
Caloric intake (kcal/day) | 1784 (1449, 2284) | 1759 (1531, 2198) |